Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dirucotide in Relapsing Remitting Multiple Sclerosis
NCT00869986Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2006
- Primary completion
- Sep 2009
- Modality
- Peptides
- Countries
- 6
01
Overview
A Phase 3 trial of dirucotide in multiple sclerosis (MS), sponsored by Eli Lilly and Company. Started Nov 2006; status: completed.
02
Drugs
dirucotide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00869986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869986.